3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
2
Thrombocythemia, Essential
1
Stomatitis
1
Stomach Neoplasms
1
Radiation Pneumonitis
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Glioblastoma
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Chemotherapy-Related Cognitive Impairment
1
Breast Neoplasms
1
Attention Deficit Disorder with Hyperactivity
1
Acute Kidney Injury
1
Interventions
Magnetic Resonance Spectroscopy
8
Specimen Handling
7
Biopsy
6
X-Rays
5
Phantoms, Imaging
5
Temozolomide
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Carboplatin
4
selpercatinib
3
larotrectinib
3
Topotecan
3
Etoposide
3
Cyclophosphamide
3
Cisplatin
3
Automobiles
3
tazemetostat
2
pembrolizumab
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Vincristine
2
Surveys and Questionnaires
2
Radiotherapy
2
Radiosurgery
2
Radiation
2
Positron-Emission Tomography
2
Paclitaxel
2
ONC206
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Acetylcysteine
×
1 year
×
Clear all
No trials found.